C/EBPA and C/EBPA oncoproteins regulate nfkb1 and displace histone deacetylases from NF-κB p50 homodimers to induce NF-κB target genes

Blood

Volumn 117, Issue 15, 2011, Pages 4085-4094

  Paz Priel, Ido ^a,b   Houng, Simone ^a   Dooher, Julia ^a   Friedman, Alan D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Bunting Blaustein Cancer   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLOHEXIMIDE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 3; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, MOUSE; NFKB1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; GENE TARGETING; HUMAN; IN VIVO STUDY; LEUKEMIA; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL; CELL STRAIN HEK293; CHEMISTRY; DIMERIZATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROMOTER REGION; TRANSGENIC MOUSE;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; DIMERIZATION; GENE EXPRESSION REGULATION, LEUKEMIC; HEK293 CELLS; HISTONE DEACETYLASES; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, TRANSGENIC; NF-KAPPA B P50 SUBUNIT; PROMOTER REGIONS, GENETIC;

EID: 79954578046     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-07-294470     Document Type: Article

References (35)

1. Friedman AD. Transcriptional control of granulocyte and monocyte development. Oncogene. 2007;26(47):6816-6828. (Pubitemid 47585105)
2. Zhang P, Iwasaki-Arai J, Iwasaki H, et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity. 2004;21(6):853-863. (Pubitemid 39642186)
3. Landschulz WH, Johnson PF, McKnight SL. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science. 1988;240(4860):1759-1764.
4. Agre P, Johnson PF, McKnight SL. Cognate DNA binding specificity retained after leucine zipper exchange between GCN4 and C/EBP. Science. 1989;246(4932):922-926. (Pubitemid 20010504)
5. Vinson CR, Sigler PB, McKnight SL. Scissorsgrip model for DNA recognition by a family of leucine zipper proteins. Science. 1989;246(4932):911-916. (Pubitemid 20010501)
6. Miller M, Shuman JD, Sebastian T, Dauter Z, Johnson PF. Structural basis for DNA recognition by the basic region leucine zipper transcription factor CCAAT/enhancer-binding protein alpha. J Biol Chem. 2003;278(17):15178-15184. (Pubitemid 36799852)
7. Frohling S, Schlenk RF, Stolze I, et al. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol. 2004;22(4):624-633. (Pubitemid 41095065)
8. Ho PA, Alonzo TA, Gerbing RB, et al. Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. Blood. 2009;113(26):6558-6566.
9. Pabst T, Mueller BU, Zhang P, et al. Dominantnegative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet. 2001;27(3):263-270. (Pubitemid 32201846)
10. Jundt F, Raetzel N, Muller C, et al. A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas. Blood. 2005;106(5):1801-1807. (Pubitemid 41208597)
11. Zahnow CA. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev Mol Med. 2009;11:e12.
12. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937-951.
13. Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med. 2004;350(16):1617-1628. (Pubitemid 38528701)
14. Kirstetter P, Schuster MB, Bereshchenko O, et al. Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell. 2008;13(4):299-310. (Pubitemid 351446194)
15. Bereshchenko O, Mancini E, Moore S, et al. Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemiainitiating cells in C/EBPalpha mutant AML. Cancer Cell. 2009;16(5):390-400.
16. Paz-Priel I, Cai DH, Wang D, et al. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Mol Cancer Res. 2005;3(10):585-596. (Pubitemid 41567277)
17. Paz-Priel I, Ghosal AK, Kowalski J, Friedman AD. C/EBPalpha or C/EBPalpha oncoproteins regulate the intrinsic and extrinsic apoptotic pathways by direct interaction with NF-kappaB p50 bound to the bcl-2 and FLIP gene promoters. Leukemia. 2009;23(2):365-374.
18. Wang D, Paz-Priel I, Friedman AD. NF-kappaB p50 regulates C/EBPalpha expression and inflammatory cytokine-induced neutrophil production. J Immunol. 2009;182(9):5757-5762.
19. Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 1986;47(6):921-928. (Pubitemid 17005065)
20. Singh H, Sen R, Baltimore D, Sharp PA. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature. 1986;319(6049):154-158. (Pubitemid 16189733)
21. Kang SM, Tran AC, Grilli M, Lenardo MJ. NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science. 1992;256(5062):1452-1456.
22. Wan F, Lenardo MJ. Specification of DNA binding activity of NF-kappaB proteins. Cold Spring Harb PerspectBiol. 2009;1(4):a000067.
23. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappaB determines its association with CBP/p300 or HDAC-1. Mol Cell. 2002;9(3):625-636. (Pubitemid 34273792)
24. Hoberg JE, Yeung F, Mayo MW. SMRT Derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival. MolCell. 2004;16(2):245-255. (Pubitemid 39388839)
25. Palacios R, Steinmetz M. IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell. 1985;41(3):727-734. (Pubitemid 15225429)
26. Yamit-Hezi A, Dikstein R. TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB. EMBO J. 1998;17(17):5161-5169. (Pubitemid 28408482)
27. Friedman AD. GADD153/CHOP, a DNA damageinducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells. Cancer Res. 1996;56(14):3250-3256. (Pubitemid 26242972)
28. Sha WC, Liou H-C, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-kappaB leads to multifocal defects in immune responses. Cell. 1995;80(2):321-330.
29. Pereira SG, Oakley F. Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol. 2008;40(8):1425-1430.
30. Caamano JH, Perez P, Lira SA, Bravo R. Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo. Mol Cell Biol. 1996;16(4):1342-1348. (Pubitemid 26095604)
31. Wessells J, Baer M, Young HA, et al. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharideinduced inflammatory responses in macrophages. J Biol Chem. 2004;279(48):49995-50003. (Pubitemid 39577809)
32. Paz-Priel I, Wang D, Ghosal A, Friedman AD. A positive feedback loop between C/EBPalpha and NF-kappaB p50 inhibits both the intrinsic and extrinsic apoptosis pathways [abstract]. Blood. 2008;112(11):Abstract 501.
33. Phelps CB, Sengchanthalangsy LL, Huxford T, Ghosh G. Mechanism of I kappa B alpha binding to NF-kappa B dimers. J Biol Chem. 2000;275(38):29840-29846. (Pubitemid 32043869)
34. Moorthy AK, Savinova OV, Ho JQ, Wang VY, Vu D, Ghosh G. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translationindependent manner. EMBO J. 2006;25(9):1945-1956.
35. Hu HM, Tian Q, Baer M, et al. The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J Biol Chem. 2000;275(21):16373-16381. (Pubitemid 30366955)